Pilot Point, TX, United States of America

Phillip B Maples

USPTO Granted Patents = 15 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 57(Granted Patents)

Company Filing History:

G-con Manufacturing, Inc.

Years Active: 2013-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350660 - Modular, self-contained, mobile clean room (2025-07-08),

2. 10654036 - Modular, self-contained, mobile clean room (2020-05-19),

3. 10253331 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2019-04-09),

4. 9914977 - Individualized cancer therapy (2018-03-13),

5. 9795957 - Modular, self-contained, mobile clean room (2017-10-24),

6. 9790518 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2017-10-17),

7. 9695422 - Furin-knockdown bi-functional RNA (2017-07-04),

8. 9528991 - Individualized cancer therapy (2016-12-27),

9. 9518748 - Modular, self-contained, mobile clean room (2016-12-13),

10. 9382589 - Individualized cancer therapy (2016-07-05),

11. 9273300 - Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy (2016-03-01),

12. 9157084 - Furin-knockdown bi-functional RNA (2015-10-13),

13. 9132146 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2015-09-15),

14. 8916530 - Individualized cancer therapy (2014-12-23),

15. 8603991 - Individualized cancer therapy (2013-12-10),

Title: Innovator Phillip B. Maples: Advancing Pharmaceutical Manufacturing Technologies

Introduction

Phillip B. Maples, hailing from Pilot Point, Texas, is a renowned inventor with a remarkable portfolio of 15 patents. His work primarily focuses on innovations within the pharmaceutical manufacturing sector, highlighting his commitment to enhancing safety and efficiency in laboratory environments.

Latest Patents

One of his latest contributions is the "Modular, self-contained, mobile clean room - Biosafety units, methods of making and sealing the same". This invention comprises a unitary structure designed to be validated for pharmaceutical manufacturing. It features at least one controlled air, sealable, sterilizable cleanroom. Additionally, the invention includes a mechanical system room separate from the cleanroom, equipped with air handling units for conditioned air supply and power distribution from multiple sources. An integrated fire suppression system and corridor connectors for further expansion are essential components, underscoring its innovative design aimed at maintaining stringent safety standards.

Career Highlights

Throughout his career, Phillip B. Maples has made significant strides in the field, particularly through his work with companies such as Gradalis, Inc. and G-CON Manufacturing, Inc. His expertise is instrumental in developing technologies that enhance the efficacy of cleanroom environments, thereby impacting pharmaceutical processes positively.

Collaborations

In his journey, he has collaborated with notable individuals, including John J. Nemunaitis and Neil Senzer. These collaborations have helped to propel his inventions forward, fostering a shared vision of improving biosafety and manufacturing processes within the pharmaceutical industry.

Conclusion

Phillip B. Maples exemplifies innovation in the field of pharmaceutical manufacturing with his groundbreaking inventions and collaborations. His contributions, particularly through the invention of advanced cleanroom technologies, indicate a thoughtful approach towards enhancing the safety and efficiency of pharmaceutical production processes. As he continues to innovate, Maples remains a key figure in advancing the capabilities within this crucial industry.

This text is generated by artificial intelligence and may not be accurate.